Detalhe da pesquisa
1.
Long Non-coding RNA Neat1, NLRP3 Inflammasome, and Acute Kidney Injury.
J Am Soc Nephrol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687867
2.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931634
3.
PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms.
Mol Biol Rep
; 51(1): 304, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361088
4.
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.
Kidney Int
; 104(6): 1219-1226, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657768
5.
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.
Cardiovasc Diabetol
; 22(1): 251, 2023 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716952
6.
The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy.
Clin Sci (Lond)
; 137(5): 317-331, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36705251
7.
Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
Nephrol Dial Transplant
; 38(10): 2232-2247, 2023 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914214
8.
Connection assist devices for peritoneal dialysis.
Semin Dial
; 2022 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117288
9.
Regulatory role and mechanisms of myeloid TLR4 in anti-GBM glomerulonephritis.
Cell Mol Life Sci
; 78(19-20): 6721-6734, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34568976
10.
Acetyl-coenzyme A carboxylase beta gene polymorphism does not predict cardiovascular risk susceptibility in Chinese type 2 diabetic individuals.
Nephrology (Carlton)
; 27(5): 404-409, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939260
11.
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Kidney Int
; 100(4): 753-779, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556300
12.
Protective role of kallistatin in renal fibrosis via modulation of Wnt/ß-catenin signaling.
Clin Sci (Lond)
; 135(3): 429-446, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33458750
13.
Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trial.
Nephrol Dial Transplant
; 36(9): 1648-1656, 2021 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32617578
14.
Update on diagnosis, pathophysiology, and management of diabetic kidney disease.
Nephrology (Carlton)
; 26(6): 491-500, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33550672
15.
Clinicopathological features of Chinese patients with B-cell lymphoproliferative disorders and kidney infiltration.
Nephrology (Carlton)
; 26(8): 650-658, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33729651
16.
Conversion from Aranesp® to NESP® in dialysis patients-Exploration of dosing strategies and the feasibility of extending the dosing interval.
Nephrology (Carlton)
; 26(9): 733-741, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844381
17.
Dialysis Care and Dialysis Funding in Asia.
Am J Kidney Dis
; 75(5): 772-781, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699518
18.
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.
Clin Sci (Lond)
; 134(21): 2873-2891, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078834
19.
Blocking Connexin-43 mediated hemichannel activity protects against early tubular injury in experimental chronic kidney disease.
Cell Commun Signal
; 18(1): 79, 2020 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450899
20.
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int
; 95(2): 268-280, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665568